Author response for "The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health‐Related Quality of Life 12 Months After Ischemic Stroke or TIA"
Manuel C. Olma(Charité - Universitätsmedizin Berlin), for the MonDAFIS Investigators, Karl Georg Hæusler(Universitätsklinikum Würzburg), Serdar Tütüncü(Charité - Universitätsmedizin Berlin), Joachim Röther(Asklepios Klinik Altona), Götz Thomalla(Universität Hamburg), L. Niehaus(Rems-Murr-Klinikum), Christian Urbanek(Klinikum Ludwigshafen), Peter U. Heuschmann(University of Würzburg), Joanna Dietzel, Johannes Schurig, Roland Veltkamp(Alfried Krupp Hospital), Paulus Kirchhof(Universität Hamburg), Cornelia Fießler(University of Würzburg), Ulrich Laufs(University Hospital Leipzig), Patrick Oschmann(Bayreuth Medical Center), Lena Steindorf‐Sabath(Charité - Universitätsmedizin Berlin), Darius G. Nabavi(Vivantes Klinikum), Claudia Kunze(Charité - Universitätsmedizin Berlin), Matthias Endres(German Center for Neurodegenerative Diseases)
Cited by 0
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k